Trial intelligence / Profile preview

Compound Danshen Dropping Pills after acute anterior ST-segment elevation myocardial infarction

ChiCTR2000033262Phase 4Recruiting

Sponsor
Jiangsu Provincial People's Hospital
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Compound Danshen in myocardial infarction (MI) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Echocardiography. Started May 2020; status: recruiting.

02

Drugs

Compound Danshen
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on ChiCTR2000033262.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000033262.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call